Literature DB >> 2571561

Coincident maternal meiotic nondisjunction of chromosomes X and 21 without evidence of autosomal asynapsis.

R S Ikonen1, M Lindlöf, M O Janas, K O Simola, A Millington-Ward, A de la Chapelle.   

Abstract

A family in which the proband showed phenotypic signs of both the Turner and Down syndromes was studied cytogenetically and with restriction fragment length polymorphisms. The proband's karyotype was 46,X,+21, showing double aneuploidy without any signs of mosaicism. The single X and one chromosome 21 were of paternal origin while two chromosome 21 were of maternal origin. The nondisjunction of chromosome 21 took place in maternal meiosis II. If it is assumed that the absence of mosaicism renders postzygotic mitotic loss of the X chromosome unlikely, then the X chromosome would have been lost in maternal meiosis I or II. Recombination had occurred between the nondisjoined chromosomes 21. We conclude that double nondisjunction took place in one patient and that asynapsis was not a prerequisite for the autosomal nondisjunction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571561     DOI: 10.1007/BF00285163

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  On the origin of recurrent trisomy 21: determination using chromosomal and DNA polymorphisms.

Authors:  A J Hamers; G P Vaes-Peeters; R J Jongbloed; A M Millington-Ward; H Meijer; C E de Die-Smulders; J P Geraedts
Journal:  Clin Genet       Date:  1987-12       Impact factor: 4.438

2.  Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome.

Authors:  A C Warren; A Chakravarti; C Wong; S A Slaugenhaupt; S L Halloran; P C Watkins; C Metaxotou; S E Antonarakis
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

3.  Chiasma frequency and maternal age in mammals.

Authors:  S A Henderson; R G Edwards
Journal:  Nature       Date:  1968-04-06       Impact factor: 49.962

4.  Trisomy 21 (Down syndrome): studying nondisjunction and meiotic recombination by using cytogenetic and molecular polymorphisms that span chromosome 21.

Authors:  G D Stewart; T J Hassold; A Berg; P Watkins; R Tanzi; D M Kurnit
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

5.  High efficiency in the attribution of parental origin of non-disjunction in trisomy 21 by both cytogenetic and molecular polymorphisms.

Authors:  F D Bricarelli; M Pierluigi; L Perroni; M Grasso; A Arslanian; N Sacchi
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

Review 6.  The genetic control of meiosis.

Authors:  B S Baker; A T Carpenter; M S Esposito; R E Esposito; L Sandler
Journal:  Annu Rev Genet       Date:  1976       Impact factor: 16.830

7.  Risk of Down syndrome among second- and third-degree relatives of a proband with trisomy 21.

Authors:  J Tamaren; K Spuhler; E Sujansky
Journal:  Am J Med Genet       Date:  1983-07

8.  The parental origin of X chromosomes in XX males determined using restriction fragment length polymorphisms.

Authors:  D C Page; A de la Chapelle
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

Review 9.  Trisomy in man.

Authors:  T J Hassold; P A Jacobs
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

10.  Use of a chromosome 21 cloned DNA probe for the analysis of non-disjunction in Down syndrome.

Authors:  K E Davies; K Harper; D Bonthron; R Krumlauf; A Polkey; M E Pembrey; R Williamson
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

View more
  2 in total

1.  A 48,XXY,+21 Down syndrome patient with additional paternal X and maternal 21.

Authors:  I Lorda-Sanchez; M B Petersen; F Binkert; M Maechler; W Schmid; P A Adelsberger; S E Antonarakis; A Schinzel
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

2.  Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance.

Authors:  Kelly L Jones; Erin A McNamara; Mauro Longoni; Danny E Miller; Mersedeh Rohanizadegan; Laura A Newman; Frances Hayes; Lynne L Levitsky; Betty L Herrington; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.